Certara
CERT · Health Care Technology
$10.33
2.4%Solventum
SOLV · Health Care Technology
$85.41
2.3%The short version
- Solventum is the larger business, with $8.3B of revenue in fiscal 2025 against $419M for Certara, about 20 times as much.
- Certara grew revenue faster (8.8%, against 0.9%).
- Solventum kept more of each dollar of sales as operating profit (26.2% operating margin, against 5.0% operating margin).
- Certara turned more of its sales into free cash flow (22.6% FCF margin, against −0.1% FCF margin).
- Solventum earned a higher return on the capital invested in it (20.4%, against 0.9%).
| Latest fiscal year | CERT · FY25 | SOLV · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.6B | $14.8B |
| Revenue | $419M | $8.3B |
| Free cash flow | $94.6M | −$10.0M |
| Net income | −$1.6M | $1.6B |
| Growth | ||
| Revenue growth | 8.8% | 0.9% |
| 5-year growth | 11.5% | — |
| Share count change | 0.0% | 0.9% |
| Profitability | ||
| Gross margin | — | 53.5% |
| Operating margin | 5.0% | 26.2% |
| Net margin | −0.4% | 18.7% |
| FCF margin | 22.6% | −0.1% |
| Return on capital | 0.9% | 20.4% |
| Return on equity | −0.2% | 38.9% |
| Balance sheet | ||
| Net debt | $104M | $4.2B |
| Net debt / EBITDA | 1.1x | 1.6x |
| Dividends and buybacks | $42.6M | $0.0M |
| Valuation & quality | ||
| P/E | — | 10.5x |
| Piotroski F-score | 5 | 5 |
FY19
CERT $209M
SOLV —
FY20
CERT $244M
SOLV —
FY21
CERT $286M
SOLV —
FY22
CERT $336M
SOLV $8.1B
FY23
CERT $354M
SOLV $8.2B
FY24
CERT $385M
SOLV $8.3B
FY25
CERT $419M
SOLV $8.3B
CERT
SOLV
FY19
CERT 9.4%
SOLV —
FY20
CERT −10.0%
SOLV —
FY21
CERT 4.8%
SOLV —
FY22
CERT 9.7%
SOLV 20.8%
FY23
CERT −11.5%
SOLV 20.6%
FY24
CERT −0.5%
SOLV 12.6%
FY25
CERT 5.0%
SOLV 26.2%
CERT
SOLV
FY19
CERT $35.9M
SOLV —
FY20
CERT $44.0M
SOLV —
FY21
CERT $59.2M
SOLV —
FY22
CERT $91.1M
SOLV $1.4B
FY23
CERT $81.0M
SOLV $1.6B
FY24
CERT $78.8M
SOLV $805M
FY25
CERT $94.6M
SOLV −$10.0M
CERT
SOLV
FY19
CERT —
SOLV —
FY20
CERT —
SOLV —
FY21
CERT 1.1%
SOLV —
FY22
CERT 2.2%
SOLV —
FY23
CERT −2.9%
SOLV —
FY24
CERT −0.1%
SOLV 7.6%
FY25
CERT 0.9%
SOLV 20.4%
CERT
SOLV
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.